Dydrogesterone

地屈孕酮

Report date: 2026/04/16 20:00:17
NME

Base Information

Drug NameDydrogesterone
Drug Alias Namedidrogesterona去氢逆孕酮去氢孕酮dydrogesteronum达芙通 +[9] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionProgesterone receptor agonists
TargetsProgesterone receptor
Therapy Area/IndicationsMenstruation DisturbancesObstetric Labor, PrematureAbortion, Habitual +[9] 
Global Approved IndicationsMenstruation DisturbancesUterine HemorrhageInfertility, Female +[4] 
Approved Indications in ChinaMenstruation DisturbancesUterine HemorrhageInfertility, Female +[4] 
Original Approved Country/TerritoryUnited Kingdom
Original Approved Date1961/01/01
Country/TerritoryBelgiumUkraineSingapore +[15] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSolvay Sa
China Registration ClassN/A

Develop Information

Active CompaniesSolvay Pharmaceuticals BvSolvay SaBeni Suef University +[4] 
Inactive CompaniesAbbott LaboratoriesAbbott Biologicals BVAbbott Products +[7] 
Active IndicationsMenstruation DisturbancesUterine HemorrhageInfertility, Female +[6] 
Inactive IndicationsObstetric Labor, PrematureAbortion, HabitualOvarian Hyperstimulation Syndrome

Other Information

ATC CodeG03DB01
Related LinksWikipediaDrugBankKEGG